Regulated intramembrane proteolysis, innate immunity and therapeutic targets in Alzheimer’s disease

The critical discovery of the presenilins and their association with familial Alzheimer’s disease (AD) prompted an intensive research effort to understand the molecular mechanisms of that disease. The presenilins were subsequently found to be the catalytic component of the multi-protein enzyme compl...

Full description

Bibliographic Details
Main Authors: Caroline Coleman-Vaughan, Indu Patwal, Justin V. McCarthy, Tara P. Hurst
Format: Article
Language:English
Published: AIMS Press 2016-04-01
Series:AIMS Molecular Science
Subjects:
Online Access:http://www.aimspress.com/Molecular/article/749/fulltext.html
_version_ 1818472018949963776
author Caroline Coleman-Vaughan
Indu Patwal
Justin V. McCarthy
Tara P. Hurst
author_facet Caroline Coleman-Vaughan
Indu Patwal
Justin V. McCarthy
Tara P. Hurst
author_sort Caroline Coleman-Vaughan
collection DOAJ
description The critical discovery of the presenilins and their association with familial Alzheimer’s disease (AD) prompted an intensive research effort to understand the molecular mechanisms of that disease. The presenilins were subsequently found to be the catalytic component of the multi-protein enzyme complex, γ-secretase, the enzyme that is known to act on the amyloid precursor protein (APP) to generate amyloid beta (Aβ) peptides that comprise the neuritic plaques implicated in AD pathology. Here, we discuss the background of γ-secretase- mediated proteolysis of APP and its association with familial AD. We discuss the association of neuroinflammation with AD, focusing on the link between the innate immune response, the clearance of the Aβ peptides and disease progression. Currently, there are limited treatments for AD that strive to ameliorate the symptoms of the disease but do not address the molecular basis of the disease. The greater understanding of γ- secretase functions has provided new insights into potential therapeutics for AD, a number of which are in clinical trials.
first_indexed 2024-04-14T03:59:50Z
format Article
id doaj.art-ff7ed68ee5cc460bb65d21fe54c3abd8
institution Directory Open Access Journal
issn 2372-0301
language English
last_indexed 2024-04-14T03:59:50Z
publishDate 2016-04-01
publisher AIMS Press
record_format Article
series AIMS Molecular Science
spelling doaj.art-ff7ed68ee5cc460bb65d21fe54c3abd82022-12-22T02:13:38ZengAIMS PressAIMS Molecular Science2372-03012016-04-013213815710.3934/molsci.2016.2.138molsci-03-00138Regulated intramembrane proteolysis, innate immunity and therapeutic targets in Alzheimer’s diseaseCaroline Coleman-Vaughan0Indu Patwal1Justin V. McCarthy2Tara P. HurstSignal Transduction Laboratory, School of Biochemistry & Cell Biology, ABCRF, Western Gateway Building, Western Road, University College Cork, Cork, IrelanSignal Transduction Laboratory, School of Biochemistry & Cell Biology, ABCRF, Western Gateway Building, Western Road, University College Cork, Cork, IrelanSignal Transduction Laboratory, School of Biochemistry & Cell Biology, ABCRF, Western Gateway Building, Western Road, University College Cork, Cork, IrelanThe critical discovery of the presenilins and their association with familial Alzheimer’s disease (AD) prompted an intensive research effort to understand the molecular mechanisms of that disease. The presenilins were subsequently found to be the catalytic component of the multi-protein enzyme complex, γ-secretase, the enzyme that is known to act on the amyloid precursor protein (APP) to generate amyloid beta (Aβ) peptides that comprise the neuritic plaques implicated in AD pathology. Here, we discuss the background of γ-secretase- mediated proteolysis of APP and its association with familial AD. We discuss the association of neuroinflammation with AD, focusing on the link between the innate immune response, the clearance of the Aβ peptides and disease progression. Currently, there are limited treatments for AD that strive to ameliorate the symptoms of the disease but do not address the molecular basis of the disease. The greater understanding of γ- secretase functions has provided new insights into potential therapeutics for AD, a number of which are in clinical trials.http://www.aimspress.com/Molecular/article/749/fulltext.htmlPresenilingamma-secretase (γ-secretase)regulated intramembrane proteolysisAlzheimer’s disease (AD)innate immune systemneuroinflammation
spellingShingle Caroline Coleman-Vaughan
Indu Patwal
Justin V. McCarthy
Tara P. Hurst
Regulated intramembrane proteolysis, innate immunity and therapeutic targets in Alzheimer’s disease
AIMS Molecular Science
Presenilin
gamma-secretase (γ-secretase)
regulated intramembrane proteolysis
Alzheimer’s disease (AD)
innate immune system
neuroinflammation
title Regulated intramembrane proteolysis, innate immunity and therapeutic targets in Alzheimer’s disease
title_full Regulated intramembrane proteolysis, innate immunity and therapeutic targets in Alzheimer’s disease
title_fullStr Regulated intramembrane proteolysis, innate immunity and therapeutic targets in Alzheimer’s disease
title_full_unstemmed Regulated intramembrane proteolysis, innate immunity and therapeutic targets in Alzheimer’s disease
title_short Regulated intramembrane proteolysis, innate immunity and therapeutic targets in Alzheimer’s disease
title_sort regulated intramembrane proteolysis innate immunity and therapeutic targets in alzheimer s disease
topic Presenilin
gamma-secretase (γ-secretase)
regulated intramembrane proteolysis
Alzheimer’s disease (AD)
innate immune system
neuroinflammation
url http://www.aimspress.com/Molecular/article/749/fulltext.html
work_keys_str_mv AT carolinecolemanvaughan regulatedintramembraneproteolysisinnateimmunityandtherapeutictargetsinalzheimersdisease
AT indupatwal regulatedintramembraneproteolysisinnateimmunityandtherapeutictargetsinalzheimersdisease
AT justinvmccarthy regulatedintramembraneproteolysisinnateimmunityandtherapeutictargetsinalzheimersdisease
AT taraphurst regulatedintramembraneproteolysisinnateimmunityandtherapeutictargetsinalzheimersdisease